Pharma & Healthcare

Global MET TKIs Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global MET TKIs market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Pfizer
Novartis
Merck
Exelixis
Haihe Biopharma
CSPC Pharmaceutical
WuXi STA
Shanghai Hutchison Pharmaceuticals
Avistone Pharmaceuticals Biotechnology
Asymchem
Wanbang Biopharmaceuticals
Drug International
Genvio Pharma
Everest Pharmaceuticals
Beacom
Teva
Cipla
BDR Pharma
Zydus
Segment by Type
Multi-target Inhibitors
Single-target Inhibitors
Segment by Application
Non-small Cell Lung Cancer
Medullary Thyroid Cancer
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the MET TKIs study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to MET TKIs: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global MET TKIs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Multi-target Inhibitors
1.2.3 Single-target Inhibitors
1.3 Market Segmentation by Application
1.3.1 Global MET TKIs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Non-small Cell Lung Cancer
1.3.3 Medullary Thyroid Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global MET TKIs Revenue Estimates and Forecasts 2020-2031
2.2 Global MET TKIs Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global MET TKIs Sales Estimates and Forecasts 2020-2031
2.4 Global MET TKIs Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global MET TKIs Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global MET TKIs Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Multi-target Inhibitors Market Size by Manufacturers
3.5.2 Single-target Inhibitors Market Size by Manufacturers
3.6 Global MET TKIs Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global MET TKIs Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global MET TKIs Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global MET TKIs Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global MET TKIs Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America MET TKIs Sales and Revenue by Type (2020-2031)
6.4 North America MET TKIs Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America MET TKIs Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe MET TKIs Sales and Revenue by Type (2020-2031)
7.4 Europe MET TKIs Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe MET TKIs Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific MET TKIs Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific MET TKIs Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific MET TKIs Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America MET TKIs Sales and Revenue by Type (2020-2031)
9.4 Central and South America MET TKIs Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America MET TKIs Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa MET TKIs Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa MET TKIs Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa MET TKIs Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview
11.1.3 Pfizer MET TKIs Product Models, Descriptions and Specifications
11.1.4 Pfizer MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Pfizer MET TKIs Sales by Product in 2024
11.1.6 Pfizer MET TKIs Sales by Application in 2024
11.1.7 Pfizer MET TKIs Sales by Geographic Area in 2024
11.1.8 Pfizer MET TKIs SWOT Analysis
11.1.9 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Business Overview
11.2.3 Novartis MET TKIs Product Models, Descriptions and Specifications
11.2.4 Novartis MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Novartis MET TKIs Sales by Product in 2024
11.2.6 Novartis MET TKIs Sales by Application in 2024
11.2.7 Novartis MET TKIs Sales by Geographic Area in 2024
11.2.8 Novartis MET TKIs SWOT Analysis
11.2.9 Novartis Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Business Overview
11.3.3 Merck MET TKIs Product Models, Descriptions and Specifications
11.3.4 Merck MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Merck MET TKIs Sales by Product in 2024
11.3.6 Merck MET TKIs Sales by Application in 2024
11.3.7 Merck MET TKIs Sales by Geographic Area in 2024
11.3.8 Merck MET TKIs SWOT Analysis
11.3.9 Merck Recent Developments
11.4 Exelixis
11.4.1 Exelixis Corporation Information
11.4.2 Exelixis Business Overview
11.4.3 Exelixis MET TKIs Product Models, Descriptions and Specifications
11.4.4 Exelixis MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Exelixis MET TKIs Sales by Product in 2024
11.4.6 Exelixis MET TKIs Sales by Application in 2024
11.4.7 Exelixis MET TKIs Sales by Geographic Area in 2024
11.4.8 Exelixis MET TKIs SWOT Analysis
11.4.9 Exelixis Recent Developments
11.5 Haihe Biopharma
11.5.1 Haihe Biopharma Corporation Information
11.5.2 Haihe Biopharma Business Overview
11.5.3 Haihe Biopharma MET TKIs Product Models, Descriptions and Specifications
11.5.4 Haihe Biopharma MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Haihe Biopharma MET TKIs Sales by Product in 2024
11.5.6 Haihe Biopharma MET TKIs Sales by Application in 2024
11.5.7 Haihe Biopharma MET TKIs Sales by Geographic Area in 2024
11.5.8 Haihe Biopharma MET TKIs SWOT Analysis
11.5.9 Haihe Biopharma Recent Developments
11.6 CSPC Pharmaceutical
11.6.1 CSPC Pharmaceutical Corporation Information
11.6.2 CSPC Pharmaceutical Business Overview
11.6.3 CSPC Pharmaceutical MET TKIs Product Models, Descriptions and Specifications
11.6.4 CSPC Pharmaceutical MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 CSPC Pharmaceutical Recent Developments
11.7 WuXi STA
11.7.1 WuXi STA Corporation Information
11.7.2 WuXi STA Business Overview
11.7.3 WuXi STA MET TKIs Product Models, Descriptions and Specifications
11.7.4 WuXi STA MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 WuXi STA Recent Developments
11.8 Shanghai Hutchison Pharmaceuticals
11.8.1 Shanghai Hutchison Pharmaceuticals Corporation Information
11.8.2 Shanghai Hutchison Pharmaceuticals Business Overview
11.8.3 Shanghai Hutchison Pharmaceuticals MET TKIs Product Models, Descriptions and Specifications
11.8.4 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Shanghai Hutchison Pharmaceuticals Recent Developments
11.9 Avistone Pharmaceuticals Biotechnology
11.9.1 Avistone Pharmaceuticals Biotechnology Corporation Information
11.9.2 Avistone Pharmaceuticals Biotechnology Business Overview
11.9.3 Avistone Pharmaceuticals Biotechnology MET TKIs Product Models, Descriptions and Specifications
11.9.4 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Avistone Pharmaceuticals Biotechnology Recent Developments
11.10 Asymchem
11.10.1 Asymchem Corporation Information
11.10.2 Asymchem Business Overview
11.10.3 Asymchem MET TKIs Product Models, Descriptions and Specifications
11.10.4 Asymchem MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Asymchem Recent Developments
11.11 Wanbang Biopharmaceuticals
11.11.1 Wanbang Biopharmaceuticals Corporation Information
11.11.2 Wanbang Biopharmaceuticals Business Overview
11.11.3 Wanbang Biopharmaceuticals MET TKIs Product Models, Descriptions and Specifications
11.11.4 Wanbang Biopharmaceuticals MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Wanbang Biopharmaceuticals Recent Developments
11.12 Drug International
11.12.1 Drug International Corporation Information
11.12.2 Drug International Business Overview
11.12.3 Drug International MET TKIs Product Models, Descriptions and Specifications
11.12.4 Drug International MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Drug International Recent Developments
11.13 Genvio Pharma
11.13.1 Genvio Pharma Corporation Information
11.13.2 Genvio Pharma Business Overview
11.13.3 Genvio Pharma MET TKIs Product Models, Descriptions and Specifications
11.13.4 Genvio Pharma MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Genvio Pharma Recent Developments
11.14 Everest Pharmaceuticals
11.14.1 Everest Pharmaceuticals Corporation Information
11.14.2 Everest Pharmaceuticals Business Overview
11.14.3 Everest Pharmaceuticals MET TKIs Product Models, Descriptions and Specifications
11.14.4 Everest Pharmaceuticals MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Everest Pharmaceuticals Recent Developments
11.15 Beacom
11.15.1 Beacom Corporation Information
11.15.2 Beacom Business Overview
11.15.3 Beacom MET TKIs Product Models, Descriptions and Specifications
11.15.4 Beacom MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Beacom Recent Developments
11.16 Teva
11.16.1 Teva Corporation Information
11.16.2 Teva Business Overview
11.16.3 Teva MET TKIs Product Models, Descriptions and Specifications
11.16.4 Teva MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Teva Recent Developments
11.17 Cipla
11.17.1 Cipla Corporation Information
11.17.2 Cipla Business Overview
11.17.3 Cipla MET TKIs Product Models, Descriptions and Specifications
11.17.4 Cipla MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Cipla Recent Developments
11.18 BDR Pharma
11.18.1 BDR Pharma Corporation Information
11.18.2 BDR Pharma Business Overview
11.18.3 BDR Pharma MET TKIs Product Models, Descriptions and Specifications
11.18.4 BDR Pharma MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 BDR Pharma Recent Developments
11.19 Zydus
11.19.1 Zydus Corporation Information
11.19.2 Zydus Business Overview
11.19.3 Zydus MET TKIs Product Models, Descriptions and Specifications
11.19.4 Zydus MET TKIs Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Zydus Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 MET TKIs Industry Chain
12.2 MET TKIs Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 MET TKIs Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 MET TKIs Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 MET TKIs Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global MET TKIs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global MET TKIs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global MET TKIs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global MET TKIs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global MET TKIs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global MET TKIs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global MET TKIs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global MET TKIs Sales by Region (2020-2025) & (K Units)
Table 8. Global MET TKIs Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global MET TKIs Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global MET TKIs Sales Share by Manufacturers (2020-2025)
Table 12. Global MET TKIs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global MET TKIs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global MET TKIs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MET TKIs as of 2024)
Table 16. Global MET TKIs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global MET TKIs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers MET TKIs Manufacturing Base and Headquarters
Table 19. Global MET TKIs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global MET TKIs Sales by Type (2020-2025) & (K Units)
Table 23. Global MET TKIs Sales by Type (2026-2031) & (K Units)
Table 24. Global MET TKIs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global MET TKIs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global MET TKIs ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global MET TKIs Sales by Application (2020-2025) & (K Units)
Table 29. Global MET TKIs Sales by Application (2026-2031) & (K Units)
Table 30. MET TKIs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global MET TKIs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global MET TKIs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global MET TKIs ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America MET TKIs Growth Accelerators and Market Barriers
Table 37. North America MET TKIs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America MET TKIs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe MET TKIs Growth Accelerators and Market Barriers
Table 40. Europe MET TKIs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe MET TKIs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific MET TKIs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific MET TKIs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific MET TKIs Growth Accelerators and Market Barriers
Table 45. Southeast Asia MET TKIs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America MET TKIs Investment Opportunities and Key Challenges
Table 47. Central and South America MET TKIs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa MET TKIs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa MET TKIs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Pfizer Corporation Information
Table 51. Pfizer Description and Major Businesses
Table 52. Pfizer Product Models, Descriptions and Specifications
Table 53. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Pfizer Sales Value Proportion by Product in 2024
Table 55. Pfizer Sales Value Proportion by Application in 2024
Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 57. Pfizer MET TKIs SWOT Analysis
Table 58. Pfizer Recent Developments
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Major Businesses
Table 61. Novartis Product Models, Descriptions and Specifications
Table 62. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Novartis Sales Value Proportion by Product in 2024
Table 64. Novartis Sales Value Proportion by Application in 2024
Table 65. Novartis Sales Value Proportion by Geographic Area in 2024
Table 66. Novartis MET TKIs SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Merck Corporation Information
Table 69. Merck Description and Major Businesses
Table 70. Merck Product Models, Descriptions and Specifications
Table 71. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Merck Sales Value Proportion by Product in 2024
Table 73. Merck Sales Value Proportion by Application in 2024
Table 74. Merck Sales Value Proportion by Geographic Area in 2024
Table 75. Merck MET TKIs SWOT Analysis
Table 76. Merck Recent Developments
Table 77. Exelixis Corporation Information
Table 78. Exelixis Description and Major Businesses
Table 79. Exelixis Product Models, Descriptions and Specifications
Table 80. Exelixis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Exelixis Sales Value Proportion by Product in 2024
Table 82. Exelixis Sales Value Proportion by Application in 2024
Table 83. Exelixis Sales Value Proportion by Geographic Area in 2024
Table 84. Exelixis MET TKIs SWOT Analysis
Table 85. Exelixis Recent Developments
Table 86. Haihe Biopharma Corporation Information
Table 87. Haihe Biopharma Description and Major Businesses
Table 88. Haihe Biopharma Product Models, Descriptions and Specifications
Table 89. Haihe Biopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Haihe Biopharma Sales Value Proportion by Product in 2024
Table 91. Haihe Biopharma Sales Value Proportion by Application in 2024
Table 92. Haihe Biopharma Sales Value Proportion by Geographic Area in 2024
Table 93. Haihe Biopharma MET TKIs SWOT Analysis
Table 94. Haihe Biopharma Recent Developments
Table 95. CSPC Pharmaceutical Corporation Information
Table 96. CSPC Pharmaceutical Description and Major Businesses
Table 97. CSPC Pharmaceutical Product Models, Descriptions and Specifications
Table 98. CSPC Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. CSPC Pharmaceutical Recent Developments
Table 100. WuXi STA Corporation Information
Table 101. WuXi STA Description and Major Businesses
Table 102. WuXi STA Product Models, Descriptions and Specifications
Table 103. WuXi STA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. WuXi STA Recent Developments
Table 105. Shanghai Hutchison Pharmaceuticals Corporation Information
Table 106. Shanghai Hutchison Pharmaceuticals Description and Major Businesses
Table 107. Shanghai Hutchison Pharmaceuticals Product Models, Descriptions and Specifications
Table 108. Shanghai Hutchison Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Shanghai Hutchison Pharmaceuticals Recent Developments
Table 110. Avistone Pharmaceuticals Biotechnology Corporation Information
Table 111. Avistone Pharmaceuticals Biotechnology Description and Major Businesses
Table 112. Avistone Pharmaceuticals Biotechnology Product Models, Descriptions and Specifications
Table 113. Avistone Pharmaceuticals Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Avistone Pharmaceuticals Biotechnology Recent Developments
Table 115. Asymchem Corporation Information
Table 116. Asymchem Description and Major Businesses
Table 117. Asymchem Product Models, Descriptions and Specifications
Table 118. Asymchem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Asymchem Recent Developments
Table 120. Wanbang Biopharmaceuticals Corporation Information
Table 121. Wanbang Biopharmaceuticals Description and Major Businesses
Table 122. Wanbang Biopharmaceuticals Product Models, Descriptions and Specifications
Table 123. Wanbang Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Wanbang Biopharmaceuticals Recent Developments
Table 125. Drug International Corporation Information
Table 126. Drug International Description and Major Businesses
Table 127. Drug International Product Models, Descriptions and Specifications
Table 128. Drug International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Drug International Recent Developments
Table 130. Genvio Pharma Corporation Information
Table 131. Genvio Pharma Description and Major Businesses
Table 132. Genvio Pharma Product Models, Descriptions and Specifications
Table 133. Genvio Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Genvio Pharma Recent Developments
Table 135. Everest Pharmaceuticals Corporation Information
Table 136. Everest Pharmaceuticals Description and Major Businesses
Table 137. Everest Pharmaceuticals Product Models, Descriptions and Specifications
Table 138. Everest Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Everest Pharmaceuticals Recent Developments
Table 140. Beacom Corporation Information
Table 141. Beacom Description and Major Businesses
Table 142. Beacom Product Models, Descriptions and Specifications
Table 143. Beacom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Beacom Recent Developments
Table 145. Teva Corporation Information
Table 146. Teva Description and Major Businesses
Table 147. Teva Product Models, Descriptions and Specifications
Table 148. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Teva Recent Developments
Table 150. Cipla Corporation Information
Table 151. Cipla Description and Major Businesses
Table 152. Cipla Product Models, Descriptions and Specifications
Table 153. Cipla Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Cipla Recent Developments
Table 155. BDR Pharma Corporation Information
Table 156. BDR Pharma Description and Major Businesses
Table 157. BDR Pharma Product Models, Descriptions and Specifications
Table 158. BDR Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. BDR Pharma Recent Developments
Table 160. Zydus Corporation Information
Table 161. Zydus Description and Major Businesses
Table 162. Zydus Product Models, Descriptions and Specifications
Table 163. Zydus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Zydus Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources


List of Figures
Figure 1. MET TKIs Product Picture
Figure 2. Global MET TKIs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Multi-target Inhibitors Product Picture
Figure 4. Single-target Inhibitors Product Picture
Figure 5. Global MET TKIs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Non-small Cell Lung Cancer
Figure 7. Medullary Thyroid Cancer
Figure 8. Other
Figure 9. MET TKIs Report Years Considered
Figure 10. Global MET TKIs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 12. Global MET TKIs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global MET TKIs Revenue Market Share by Region (2020-2031)
Figure 14. Global MET TKIs Sales (2020-2031) & (K Units)
Figure 15. Global MET TKIs Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global MET TKIs Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers MET TKIs Sales Volume Market Share in 2024
Figure 18. Global MET TKIs Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Multi-target Inhibitors Revenue Market Share by Manufacturer in 2024
Figure 21. Single-target Inhibitors Revenue Market Share by Manufacturer in 2024
Figure 22. Global MET TKIs Sales Market Share by Type (2020-2031)
Figure 23. Global MET TKIs Revenue Market Share by Type (2020-2031)
Figure 24. Global MET TKIs Sales Market Share by Application (2020-2031)
Figure 25. Global MET TKIs Revenue Market Share by Application (2020-2031)
Figure 26. North America MET TKIs Sales YoY (2020-2031) & (K Units)
Figure 27. North America MET TKIs Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers MET TKIs Sales Revenue (US$ Million) in 2024
Figure 29. North America MET TKIs Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America MET TKIs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America MET TKIs Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America MET TKIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 34. Canada MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 36. Europe MET TKIs Sales YoY (2020-2031) & (K Units)
Figure 37. Europe MET TKIs Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers MET TKIs Sales Revenue (US$ Million) in 2024
Figure 39. Europe MET TKIs Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe MET TKIs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe MET TKIs Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe MET TKIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 44. France MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 46. Italy MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 47. Russia MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific MET TKIs Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific MET TKIs Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers MET TKIs Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific MET TKIs Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific MET TKIs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific MET TKIs Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific MET TKIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 56. Japan MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 59. India MET TKIs Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America MET TKIs Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America MET TKIs Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers MET TKIs Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America MET TKIs Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America MET TKIs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America MET TKIs Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America MET TKIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil MET TKIs Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina MET TKIs Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa MET TKIs Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa MET TKIs Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers MET TKIs Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa MET TKIs Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America MET TKIs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa MET TKIs Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa MET TKIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries MET TKIs Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey MET TKIs Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt MET TKIs Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa MET TKIs Revenue (2020-2025) & (US$ Million)
Figure 80. MET TKIs Industry Chain Mapping
Figure 81. Regional MET TKIs Manufacturing Base Distribution (%)
Figure 82. Global MET TKIs Production Market Share by Region (2020-2031)
Figure 83. MET TKIs Production Process
Figure 84. Regional MET TKIs Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies